Leal Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17 Briden St Ofc 329, Worcester, Massach...Website
www.lealtx.comRevenue
$8.7 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
2
1
1
1
1
About Leal Therapeutics
Leal Therapeutics is a clinical-stage biopharmaceutical company developing neuro-metabolic therapeutics for central nervous system (CNS) disorders. Their platform leverages human genetics, functional genomics, biomarker analyses, and a proprietary antibody-like shuttle technology to enable brain-penetrant small molecule and nucleic acid therapies.Explore more
Leal Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leal Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Leal Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Leal Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Leal Therapeutics
Check out if Leal Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Leal Therapeutics launches new products
Funding: Get notified immidiatlly once Leal Therapeutics has new funding data
Earning: See what the market has to say on Leal Therapeutics recently announced quarterly report
Check if Leal Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Leal Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Leal Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Leal Therapeutics.
Leal Therapeutics financials insights
Gather financial insights about Leal Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Seed
$39M
2024
Other Financing Round
$45M
2026
Series A
$60M
Leal Therapeutics Tech Stack
A closer look at the technologies used by Leal Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Leal Therapeutics News & Media
Leal Therapeutics Inks $30 Million Series A Extension
WORCESTER, MA, Leal Therapeutics, Inc. (Leal), a clinical-stage biopharmaceutical company, announced a second close of $30 million of its Series A financing.Leal Therapeutics Announces $30 Million Series A Extension and Initiation of Phase 1b/2a Clinical Trial of LTX-001 in Schizophrenia
Phase 1b/2a clinical trial assessing safety and efficacy of LTX-001 in adults with schizophrenia initiated Financing advances LTX-001 through initial readout from Phase 1b/2a trial and progresses LTX-002 through additional dosing cohorts of ongoing Phase 1/2 trial in ALS WORCESTER, Mass.,...Leal Therapeutics Announces Executive Leadership Appointments and Provides Business Update
WORCESTER, Mass., April 13, 2026 /PRNewswire/ -- Leal Therapeutics, Inc. (Leal), a biotechnology company developing neuro-metabolic therapeutics, today announced the appointments of Johannes Tauscher, M.D., as Chief Medical Officer and Raymond Jordt, M.B.A., M.S., as Chief Business...Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet need CNS disorders Financing advances LTX-001 through clinical efficacy data in schizophrenia patients, LTX-002 through initial clinical data in ALS, and...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leal Therapeutics
Sign Up For FreeTo access detailed company insights
Leal Therapeutics is a clinical-stage biopharmaceutical company developing neuro-metabolic therapeutics for central nervous system (CNS) disorders. Their platform leverages human genetics, functional genomics, biomarker analyses, and a proprietary antibody-like shuttle technology to enable brain-penetrant small molecule and nucleic acid therapies.... Read More
